Delivery Order SPE2DB20D1100-SPE2DB25FA1E2
Award Date
1/16/25
Potential Completion Date
1/17/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,312.39 firm fixed-price delivery order is for the supply of 4,566,422,771 units of the 50 mg lisdexamfetamine capsule product. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $18,650.71, is for the delivery of 4,566,893,252 units of the prescription drug lisdexamfetamine 40 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 13, 2025. This award is not designated as a set-aside...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,686.15 firm fixed-price contract is for the delivery of 4,567,031,162 units of the prescription medication lisdexamfetamine 30 mg capsules. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.00 firm fixed-price delivery order is for the supply of 4,566,554,642 units of 60 mg lisdexamfetamine capsules in 100-count bottles. The contract has an ultimate completion date of November 27, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,980.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 10 mg capsules, with an ultimate completion date of January 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,051.86 firm fixed-price contract is for the supply of 4,567,172,718 units of the prescription drug lisdexamfetamine 10 mg capsules. The award has a period of performance through February 6, 2025 and is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.26 firm fixed-price delivery order contract is for the supply of 100-count lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,566,865,906 units of the pharmaceutical drug lisdexamfetamine 20 mg capsules in 100-count bottles. The contract has a ceiling value of $1,674.03 and is a firm fixed-price delivery order contract type. The period of performance runs through January 8, 2025. This...
This is a $2,140.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,979,063 units of 30mg lisdexamfetamine capsules, a prescription medication. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,554.25, is a Firm Fixed Price Delivery Order for the supply of 4,567,019,989 units of lisdexamfetamine 40 mg capsules. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...